Multaq 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FPX0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,621
Award facts
- Contract value 100% obligated
- $20,620.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,620.84 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract valued at $999,999,999.00 with DLA Troop Support Medical extending through December 31, 2031, serving as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order represents routine pharmaceutical procurement through DLA's medical supply chain, which distributes essential medications to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the type of specialty pharmaceutical products that AmerisourceBergen supplies to support Department of Defense healthcare operations. The contractor's extensive federal contracting history and demonstrated capability across multiple therapeutic domains position it as a critical vendor for federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26FPX0N?
SPE2DR26FPX0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FPX0N worth?
The government has obligated $20,621 on SPE2DR26FPX0N.
Is contract SPE2DR26FPX0N an order under another contract?
Yes. SPE2DR26FPX0N is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPX0N competed?
The extent of competition for SPE2DR26FPX0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award